In infants, children, and adolescents, the most common indication for coronary artery bypass graft surgery (CABG) has been Kawasaki disease or acquired familial hypercholesterolemia. However, pediatric CABG is now more commonly performed for coronary artery injuries which occur during or following arterial switch operations (ASO), the Ross procedure, and tetralogy of Fallot repairs (TOF).1-3 CABG has also been performed in adults who present with acquired coronary atherosclerotic disease and have congenital lesions such as TOF.
4In adult CABG surgery, the internal mammary artery (IMA) is the conduit of choice because of its superior long-term patency. However, in infants, children, and adolescents, concerns have been raised regarding the use of the IMA because of competitive flow, the smaller diameter of the IMA, the size of the target vessel, the need for the IMA to provide the entire blood supply for large areas of the myocardium, and the potential of the IMA for somatic growth.In this edition of the Journal, Arnaz et al 5 report their experience with CABG surgery in 10 children ranging from 88 days to 15 years. The indications for CABG included complications related to the ASO and the Ross procedure and iatrogenic injuries due to the anomalous location of coronary arteries during TOF repairs. Three patients died during the postoperative period, but none of the deaths were due to coronary ischemia. Eight patients received an IMA graft and two patients received saphenous vein grafts. Four of the eight IMA grafts underwent follow-up angiograms which showed patent IMA grafts in all patients.In two of these patients, the IMA grafts showed somatic growth after 9.5 and 18 years. None of the surviving seven patients had any recurrent angina, new Q waves, or a reduction in ejection fraction.Although the number of patients in this series is small, it confirms the results of other studies which have demonstrated that the IMA has excellent long-term patency and adapts well to somatic growth.